BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23557411)

  • 1. Prospective randomized trial of the effect of octreotide on pancreatic juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage.
    Fernández-Cruz L; Jiménez Chavarría E; Taurà P; Closa D; Boado MA; Ferrer J
    HPB (Oxford); 2013 May; 15(5):392-9. PubMed ID: 23557411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
    You DD; Paik KY; Park IY; Yoo YK
    Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of octreotide in the prevention of complications after pancreaticoduodenectomy in patients with soft pancreas and non-dilated pancreatic duct: A prospective randomized trial.
    El Nakeeb A; ElGawalby A; A Ali M; Shehta A; Hamed H; El Refea M; Moneer A; Abd El Rafee A
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):59-63. PubMed ID: 29428106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease.
    Lowy AM; Lee JE; Pisters PW; Davidson BS; Fenoglio CJ; Stanford P; Jinnah R; Evans DB
    Ann Surg; 1997 Nov; 226(5):632-41. PubMed ID: 9389397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.
    Kollmar O; Moussavian MR; Richter S; de Roi P; Maurer CA; Schilling MK
    Eur J Surg Oncol; 2008 Aug; 34(8):868-875. PubMed ID: 18299182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide Does Not Prevent Pancreatic Fistula Following Pancreatoduodenectomy in Patients with Soft Pancreas and Non-dilated Duct: A Prospective Randomized Controlled Trial.
    Kurumboor P; Palaniswami KN; Pramil K; George D; Ponnambathayil S; Varma D; Aikot S
    J Gastrointest Surg; 2015 Nov; 19(11):2038-44. PubMed ID: 26302879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy prevention of pancreatic fistula after pancreaticoduodenectomy].
    Slim K; Le Borgne J
    Ann Chir; 2003 Apr; 128(3):175-6. PubMed ID: 12821085
    [No Abstract]   [Full Text] [Related]  

  • 8. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial.
    Yeo CJ; Cameron JL; Lillemoe KD; Sauter PK; Coleman J; Sohn TA; Campbell KA; Choti MA
    Ann Surg; 2000 Sep; 232(3):419-29. PubMed ID: 10973392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy.
    Poon RT; Lo SH; Fong D; Fan ST; Wong J
    Am J Surg; 2002 Jan; 183(1):42-52. PubMed ID: 11869701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.
    Barnett SP; Hodul PJ; Creech S; Pickleman J; Arahna GV
    Am Surg; 2004 Mar; 70(3):222-6; discussion 227. PubMed ID: 15055845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial.
    Montorsi M; Zago M; Mosca F; Capussotti L; Zotti E; Ribotta G; Fegiz G; Fissi S; Roviaro G; Peracchia A
    Surgery; 1995 Jan; 117(1):26-31. PubMed ID: 7809832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.
    Graham JA; Johnson LB; Haddad N; Al-Kawas F; Carroll J; Jha R; Wong J; Maglaris D; Mertens S; Fishbein T
    Am J Surg; 2011 Apr; 201(4):481-5. PubMed ID: 21421102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.
    Vanounou T; Pratt WB; Callery MP; Vollmer CM
    J Am Coll Surg; 2007 Oct; 205(4):546-57. PubMed ID: 17903728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
    Briceño Delgado FJ; López Cillero P; Rufián Peña S; Solórzano Peck G; Miño Fugarolas G; Pera Madrazo C
    Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pancreatic juice length in the stent tube as the predicting factor of clinical relevant postoperative pancreatic fistula after pancreaticoduodenectomy.
    Wang H; Xiu D; Tao M
    Medicine (Baltimore); 2017 Nov; 96(44):e8451. PubMed ID: 29095290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of octreotide on pancreatic fistula after pancreaticoduodenectomy: a prospective study].
    Kong R; Hu J; Li L; Wang G; Chen H; Bai X; Wang Y; Wu L; Jiang H; Sun B
    Zhonghua Wai Ke Za Zhi; 2016 Jan; 54(1):21-4. PubMed ID: 26792348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial.
    Andrianello S; Marchegiani G; Malleo G; Masini G; Balduzzi A; Paiella S; Esposito A; Landoni L; Casetti L; Tuveri M; Salvia R; Bassi C
    JAMA Surg; 2020 Apr; 155(4):313-321. PubMed ID: 32101272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
    Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O
    Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.